Other Platinum-based Agents

Platinum is a relatively rare earth metal usually found with related metals osmium and iridium. While it has a number of industrial applications, its common consumer application is in catalytic converters. This application has actually increased platinum concentrations in roadside dust. The ability of platinum and its derivatives to kill cells or inhibit cell division was discovered in 1965. Platinum-based drugs, such as cisplatin, are used to treat ovarian and testicular cancer, and cancers of the head and neck, as well as others. Unfortunately, the toxic side effects of these agents often limit their usefulness. 

In the case of flame retardant silicone elastomer, many ingredients such as silica, platinum, and other flame retardant agents are incorporated into the base siloxane polymer. But there is no need to use the halogenated flame retardant agent, for example, bromine or chlorine compounds. This difference is an advantage of silicones compared with other synthetic polymers in terms of health and safety. 

For exchange of non-labile organic hydrogen atoms, acid-base catalysis (or some other catalytic hydrogen-transfer agent such as palladium or platinum) is required. The method routinely gives tritiated products having a specific activity almost 1000 times that obtained by the Wilzbach method shorter times are required (2-12h) and subsequent purification is easier. 

In our group, a major part of our research is devoted to the design of new anticancer drugs. Our recent efforts towards the discovery of new platinum-, ruthenium- and osmium-based anticancer agents provide the topic for this account and a section is devoted to each metal. We focus on recent results from our lab in the context of other developments and related research in this field (hence our coverage of the field is focused on these areas and is not comprehensive). 

---